Omega Healthcare Investors (OHI) Posts Earnings Results, Misses Estimates By $0.18 EPS

Omega Healthcare Investors (NYSE:OHI) posted its quarterly earnings data on Tuesday. The real estate investment trust reported $0.31 EPS for the quarter, missing the Zacks’ consensus estimate of $0.49 by ($0.18), Yahoo Finance reports. The company had revenue of $221.21 million during the quarter, compared to analyst estimates of $219.07 million. Omega Healthcare Investors had a return on equity of 3.92% and a net margin of 17.61%.

Shares of Omega Healthcare Investors (OHI) traded down $1.43 during mid-day trading on Wednesday, reaching $25.53. The company’s stock had a trading volume of 3,884,662 shares, compared to its average volume of 2,408,700. The company has a market capitalization of $5,020.00, a P/E ratio of 33.59, a P/E/G ratio of 2.72 and a beta of 0.41. The company has a debt-to-equity ratio of 1.18, a quick ratio of 3.40 and a current ratio of 3.40. Omega Healthcare Investors has a 1-year low of $24.90 and a 1-year high of $35.14.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st will be issued a $0.66 dividend. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.65. This represents a $2.64 dividend on an annualized basis and a yield of 10.34%. The ex-dividend date of this dividend is Tuesday, January 30th. Omega Healthcare Investors’s payout ratio is presently 347.37%.

In other Omega Healthcare Investors news, Director Bernard J. Korman bought 100,000 shares of the stock in a transaction on Friday, December 22nd. The stock was acquired at an average cost of $26.89 per share, for a total transaction of $2,689,000.00. Following the completion of the acquisition, the director now owns 896,895 shares in the company, valued at approximately $24,117,506.55. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.54% of the company’s stock.

A number of research firms recently commented on OHI. Stifel Nicolaus reaffirmed a “hold” rating and issued a $27.00 price objective (down from $29.00) on shares of Omega Healthcare Investors in a research note on Wednesday. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $34.00 price objective on shares of Omega Healthcare Investors in a research note on Tuesday. ValuEngine lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Capital One Financial began coverage on Omega Healthcare Investors in a research note on Monday, October 23rd. They issued an “equal weight” rating and a $34.00 price objective on the stock. Finally, SunTrust Banks reaffirmed a “hold” rating and issued a $30.00 price objective on shares of Omega Healthcare Investors in a research note on Wednesday, November 1st. Three analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $31.57.

WARNING: This piece of content was reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Earnings History for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with's FREE daily email newsletter.

Leave a Reply